About Liquid Biotech
Liquid Biotech is a Healthcare company based in Audubon (United States) founded in 2015. Telomerase-based liquid biopsy tests are provided for tumor detection. Liquid Biotech has raised $2 million across 1 funding round from investors including Oncolys BioPharma. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Liquid Biopsy. Its competitors include Guardant Health, GRAIL and Foundation Medicine; 3 of its 3 listed competitors have raised funding.
Company details
Liquid Biotech was founded in 2015 and is headquartered in Audubon, United States. Focus is placed on the biotechnology sector, particularly oncology diagnostics. Telomerase-based liquid biopsy tests are developed using recombinant viral vectors. These vectors enable fluorescence detection in circulating tumor cells, determined by telomerase activity levels. Services are directed toward non-invasive cancer monitoring and analysis.
- Headquarters Audubon, United States
- SectorsHealthcare
- Website liquidbiotechusa.com
- Social LinkedIn
- Total Equity Funding$2M (USD)
in 1 rounds
- Latest Funding Round$2M (USD), Seed
Dec 2015
- Investors
Funding Insights of Liquid Biotech
Liquid Biotech has successfully raised a total of $2M through 1 strategic funding round. The most recent funding activity was a Seed round of $2 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 1
- Last Round Seed — $2M
- First Round $2M
(Dec 2015)
- Investors Count 1
All 1 funding rounds of Liquid Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2015 | $2M | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Liquid Biotech
Liquid Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Oncolys BioPharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Oncolytic virus therapies for cancer and infectious diseases are developed. | 2004 | oncolys.com | Chiba, Japan |
Investor details for Liquid Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Liquid Biotech
2 dated milestones of Liquid Biotech, from founding to its latest funding, stage changes and deals.
- Founded Liquid Biotech is founded.
- Funding First funding round of $2.0M.
Competitors of Liquid Biotech
Liquid Biotech has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, GRAIL and Foundation Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. |
Detailed competitors of Liquid Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Liquid Biotech (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Liquid Biotech
Liquid Biotech was founded in 2015.
Liquid Biotech is headquartered in Audubon, United States. It is registered at Audubon, New Jersey, United States.
Liquid Biotech is a funded company, having raised a total of $2M across 1 funding round to date. The company's 1st funding round was a Seed of $2M, raised on Dec 2015.
Liquid Biotech was founded in 2015 and is headquartered in Audubon, United States. Focus is placed on the biotechnology sector, particularly oncology diagnostics. Telomerase-based liquid biopsy tests are developed using recombinant viral vectors. These vectors enable fluorescence detection in circulating tumor cells, determined by telomerase activity levels. Services are directed toward non-invasive cancer monitoring and analysis.
Liquid Biotech's top competitors include Guardant Health, GRAIL and Foundation Medicine.
Liquid Biotech has 1 investor. Key investors include Oncolys BioPharma.